Business Wire

Soracom Partners with ThingsMatrix to Deliver Turnkey Services for Enterprise IoT

Share

Soracom, Inc., a global provider of advanced Internet of Things (IoT) connectivity, today announced that ThingsMatrix, an experienced IoT solutions provider that offers full turnkey services, has joined the Soracom Partner Space – a growing ecosystem for building and scaling IoT applications to advance asset monitoring for industrial enterprises.

ThingsMatrix offers a robust cloud-based platform designed to simplify IoT development and deployment processes for enterprises. The company’s turnkey solution includes three versatile components – device, platform and cellular connectivity – enabling a full range of functionality from simple tasks to complex actions. With custom, off-the-shelf, or bring your own devices available to track and monitor assets globally, ThingsMatrix offers the speed, security and scalability today’s industrial enterprises need to navigate the complexities of IoT, thus reducing risk and accelerating time-to-value.

“ThingsMatrix’s versatile turnkey device solutions and service platform paired with Soracom’s reliable and advanced IoT capabilities is a major step forward for total asset management,” said Tom Burton, ThingsMatrix’s president of global sales. “This collaboration means that industrial enterprises will now have the ability to solve complex issues with an all-in-one IoT solution that offers greater efficiency and seamless connectivity.”

Soracom announced the global expansion of the Soracom Partner Space in May 2022. The program now reaches more than 800 best-in-class members throughout the world, including more than 100 certified partners representing hardware, software, solutions, and integration services. Soracom Partner Space members help IoT innovators accelerate time to market with as-needed access to complementary, best-in-class solutions and services that are ready to integrate at every level of the IoT stack.

“Soracom is committed to democratizing the technologies that help IoT innovators accelerate speed to market and ensure success at scale,” said Nicolas Lesconnec, Soracom senior partnership manager. “In collaborating with ThingsMatrix, we are able to offer a proven portfolio of solutions to our customers and ecosystem partners looking to improve their asset monitoring capabilities.”

For more information, visit www.soracom.io/partners/thingsmatrix

About ThingsMatrix

ThingsMatrix is a world-class, global IoT solutions provider offering hardware, device management platform and connectivity. The company’s customizable and off-the-shelf solutions enable enterprises to simplify asset tracking, improve operations and reduce costs by remotely managing multiple devices and locations in a robust, unified dashboard. ThingsMatrix’s configurable and programmable architecture provides companies with a full range of functionality to securely collect, process, analyze and visualize IoT data in real time. Built on efficiency, versatility and affordability, the company’s turnkey solutions are designed to meet the needs of a wide range of vertical industries — from global leading operators to single contract customers. For more information, visit www.things-matrix.com.

About Soracom

Soracom is leading the democratization of IoT connectivity, offering robust solutions specifically designed to make it easy to build, operate, and scale IoT deployments. Founded in 2015, Soracom now serves more than 20,000 startups, SMBs and global enterprises across all industries, from agriculture, energy, construction and transportation to consumer electronics, manufacturing, real estate and healthcare. Customers trust Soracom for affordable, reliable connectivity that accelerates speed to market, makes it easy to connect to the cloud, and offers access to a worldwide partner ecosystem. More information is available at www.soracom.io.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Justine Schneider
Calysto Communications
jschneider@calysto.com
O: 404-266-2060, ext. 507

Patti Bianchi
LimeLight Resources Inc. (for ThingsMatrix)
pbianchi@limelightresources.com
M: 630-841-1771

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IFF Unveils Nourish Innovation Lab in Union Beach, New Jersey19.8.2022 12:55:00 CEST | Press release

IFF (NYSE:IFF) today announced the opening of its new Nourish Innovation Lab at the company’s Union Beach, New Jersey research and development center. In the state-of-the-art lab, scientists—including flavorists and food designers—will leverage tools, technologies and ingredient expertise to offer customers full product design, driving growth in the global food and beverage markets by fast forwarding innovation. “This new facility is a testament to how we pioneer innovation and drive speed to market and accessibility to our customers,” said Nicolas Mirzayantz, president of Nourish, IFF. “We will nurture an innovation project from concept to kitchen table, under one roof. Using our scientific knowhow, application excellence and full portfolio of ingredients, we’ll improve the taste and nutrition profiles of next-generation food and beverages. With our new culinary kitchen, we’re enabling technology focused on the consumer-eating experience, taking food development out of the traditional

PUMA Ambassador and European Champion Gianmarco Tamberi Talks “Only See Great”19.8.2022 11:52:00 CEST | Press release

Six years after his first gold medal, Tamberi takes back the European title and speaks about his motivation to keep performing at the highest level in a video interview with sports company PUMA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220819005125/en/ Six years after his first gold medal, Tamberi takes back the European title and speaks about his motivation to keep performing at the highest level in a video interview with sports company PUMA. (Photo: Business Wire) With the ‘Only See Great’ campaign, PUMA explores the career path of its brand ambassadors, as they talk about their own pursuit of greatness, listening to their hearts, and finding a vision that no one else can see. In the interview, Gianmarco talks about his very first successes and extraordinary performance at the Olympic Games in Tokyo. “That feeling that I had that day, that happiness I couldn’t even imagine that could exist. It’s something that was co

Kyowa Kirin Receives European Commission Approval for Use of CRYSVITA ® ▼ (burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)19.8.2022 10:30:00 CEST | Press release

Kyowa Kirin Co., Ltd. (TSE: 4151, Kyowa Kirin) today announced that the European Commission (EC) approved CRYSVITA® (burosumab) for the treatment of FGF23-related hypophosphataemia in Tumour-Induced Osteomalacia (TIO) associated with phosphaturic mesenchymal tumours (PMTs) that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.1 CRYSVITA is also already licensed in the EU for use in the rare disease X-Linked Hypophosphataemia (XLH), for children and adolescents between 1 and 17 years of age with radiographic evidence of bone disease, and in adults.2 Also known as oncogenic osteomalacia, TIO is an acquired disorder caused by typically small, slow-growing, benign PMTs.3,4 It is a rare condition with fewer than 1000 cases reported in the medical literature,4 which mainly affects adults and with a mean onset age of 40 – 45 years.3,5 TIO is associated with progressive and debilitating musculoskeletal deficits,6,7 ultimately having a detr

Kapruvia ® approved in Switzerland with additional regulatory decisions expected in H2 202219.8.2022 07:00:00 CEST | Press release

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that they have received approval for Kapruvia® from the Swiss Agency for Therapeutic Products (Swissmedic). Kapruvia® will be the first therapy available for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult hemodialysis patients. Swissmedic approval for Kapruvia® follows approvals by the U.S. Food and Drug Administration, by the European Medicines Agency, by the UK Medicines and Healthcare products Regulatory Agency, as well as by Health Canada. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220818005552/en/ “The approval of Kapruvia® in Switzerland is the next step on our journey to bring this breakthrough treatment to hemodialysis patients living with CKD-associated pruritus around the world,” said Dr. Klaus Henning Jensen, Chief Medical Officer of CSL Vifor. “There is a

European Commission Approves Celltrion Healthcare’s Vegzelma™ (CT-P16, biosimilar bevacizumab) for the Treatment of Multiple Types of Cancer19.8.2022 04:47:00 CEST | Press release

Celltrion Healthcare announced today that the European Commission (EC) has approved Vegzelma™ (CT-P16), a biosimilar bevacizumab referencing EU-approved Avastin®, for the treatment of metastatic breast cancer, non-small cell lung cancer, advanced and/or metastatic renal cell cancer, metastatic carcinoma of the colon or rectum, ovarian cancer and cervical cancer. “The European Commission’s approval of Vegzelma™ will increase access to treatment for patients living with certain types of cancer at an affordable price,” said Kevin Byoung Seo Choi, Senior Vice President and Head of Marketing Division at Celltrion Healthcare. “With proven similarities in efficacy and safety compared to the reference product Avastin®, Vegzelma™ will be available to treat some of the most commonly diagnosed cancers, which collectively affect hundreds of thousands of European patients each year.” The EC approval of Vegzelma™ follows the recommendation for marketing authorisation issued by the Committee for Medi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom